22nd Century AI Stock Analysis
Want to see XXII full AI Analyst Report?
22nd Century (XXII) AI Stock Analysis
22nd Century
(NASDAQ:XXII)
Persistent losses and negative cash flow are the primary constraints, reinforced by a severe technical downtrend and weak valuation support. Improving quarterly operating trends, retail expansion, and available liquidity provide some upside potential but do not yet outweigh the company's financial and dilution risks.
22nd Century (XXII) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $137.32K
- Dividend Yield
- ―
- Average Volume (3M)
- 1.19M
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- 2.98
- Revenue Growth
- -15.53%
- EPS Growth
- 99.45%
- Country
- US
- Employees
- 32
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
22nd Century Business Overview & Revenue Model
Company Description
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product se...
How the Company Makes Money
The company’s primary monetization approach has been generating revenue from the sale of tobacco products (including reduced-nicotine cigarettes) and from commercial arrangements tied to its plant-technology intellectual property (e.g., licensing, te...
22nd Century Earnings Call Summary
The call was predominantly positive. Management reported strong sequential revenue growth, improved gross profit and losses, a 166% increase in reported same-store sales for Pinnacle Pure branded products, expanding retail distribution, planned Gopuff access, simplified capitalization, and cash expected to fund operations well into 2027. These positives outweighed the nine-month revenue decline, ongoing losses, higher year-over-year operating expenses, modestly worse nine-month Adjusted EBITDA, and remaining distribution gaps.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management expects the legacy CMO wind-down to be “substantially complete by the end of 2026,” expects the Gopuff initiative to “begin in the fourth quarter,” with the objective of establishing “a well-developed direct-to-consumer operating model as we enter 2027,” and said the company has sufficient cash to fund operations “well into 2027 based on management's current outlook,” with a focus on achieving cash flow breakeven “before the additional capital becomes needed.” Management said gross margins of “50% or more are achievable at scale,” targets availability in every state where the products are authorized and in “as many of the more than 272,000 U.S. retail locations that sell cigarettes as possible,” and identified a serviceable addressable market of “approximately $35 billion annually” within a U.S. tobacco market of “approximately $70 billion in annual sales,” including “roughly $50 billion” in cigarettes.
22nd Century Financial Statement Overview
Summary
Revenue improved and the balance sheet remains relatively sound with low debt, but negative gross profit, a $12.2 million net loss, and approximately $5.9 million of negative operating and free cash flow indicate substantial financial weakness.
Income Statement
15Very NegativeBalance Sheet
68PositiveCash Flow
22Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.78M | 7.05M | 11.88M | 32.20M | 40.50M | 30.95M |
| Gross Profit | -1.32M | -3.14M | -2.40M | -8.70M | 1.85M | 1.49M |
| EBITDA | -10.61M | -10.53M | -12.11M | -40.41M | -32.89M | -31.00M |
| Net Income | -12.21M | -5.05M | -15.16M | -140.78M | -59.80M | -32.61M |
Balance Sheet | ||||||
| Total Assets | 23.36M | 27.02M | 21.67M | 27.50M | 114.65M | 75.95M |
| Cash, Cash Equivalents and Short-Term Investments | 3.91M | 7.15M | 4.42M | 2.06M | 20.40M | 48.74M |
| Total Debt | 1.47M | 4.21M | 8.62M | 16.38M | 4.65M | 2.34M |
| Total Liabilities | 7.28M | 11.27M | 17.66M | 35.91M | 18.68M | 9.88M |
| Stockholders Equity | 16.08M | 15.76M | 4.01M | -8.41M | 95.97M | 66.07M |
Cash Flow | ||||||
| Free Cash Flow | -6.24M | -8.60M | -14.51M | -60.60M | -56.14M | -23.91M |
| Operating Cash Flow | -5.89M | -7.72M | -14.35M | -54.99M | -51.71M | -22.84M |
| Investing Cash Flow | -1.37M | -505.00K | -139.00K | 16.82M | 22.58M | -27.73M |
| Financing Cash Flow | 6.32M | 10.96M | 16.85M | 37.21M | 30.82M | 50.88M |
22nd Century Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XXII, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 2.93, below the 50-day MA of 38.87, and below the 200-day MA of 1386.43, indicating a bearish trend. The MACD of -11.71 indicates Negative momentum. The RSI at 16.33 is Positive, neither overbought nor oversold. The STOCH value of 2.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XXII.
22nd Century Risk Analysis
22nd Century disclosed 34 risk factors in its most recent earnings report. 22nd Century reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New Risks22nd Century Peers Comparison
Overall Rating
TPB57Neutral
ISPR47Neutral
UVV43Neutral
XXII42Neutral
KAVL42Neutral
GNLN39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 57Neutral | $949.55M | 32.65 | 6.97% | 0.68% | 23.78% | -51.37% | |
| 47Neutral | $73.36M | -1.92 | 165.45% | ― | -21.35% | 2.18% | |
| 43Neutral | $822.09M | -322.30 | -0.17% | 10.24% | -8.88% | -102.19% | |
| 42Neutral | $219.19K | 0.00 | -68.11% | ― | -15.53% | 99.45% | |
| 42Neutral | $390.71K | -0.02 | -9999.00% | ― | -75.31% | -17.46% | |
| 39Underperform | $643.31K | -0.00 | -249.60% | ― | -57.94% | 99.51% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| XXII | 22nd Century Group | 0.34 | -14493.88 | -100.00% | |
| UVV | Universal Corporation | 32.23 | -16.21 | -33.46% | |
| TPB | Turning Point Brands Inc | 46.36 | -50.11 | -51.94% | |
| GNLN | Greenlane Holdings | 0.51 | -26.57 | -98.11% | |
| KAVL | Kaival Brands Innovations Group Inc | 0.02 | -0.45 | -96.34% | |
| ISPR | Ispire Technology, Inc. | 1.23 | -1.05 | -46.05% |
22nd Century Corporate Events
22nd Century Announces 1-for-58 Reverse Stock Split
NeutralOn November 3, 2026, 22nd Century Group announced a 1-for-58 reverse stock split as a measure to restore compliance with NASDAQ Capital Market continued-listing standards. The announcement set the effective time at 12:01 a.m. Eastern time on November...
22nd Century Expands Sales Agreement, Adds Clear Street
PositiveOn October 27, 2026, 22nd Century Group, Inc. amended its existing sales agreement originally executed with Needham & Company LLC on November 4, 2025 and previously amended on March 31, 2026. The new amendment adds Clear Street LLC as an additional s...
22nd Century Group Expands At-The-Market Stock Offering
NegativeOn October 23, 2026, 22nd Century Group, Inc. filed a prospectus supplement with the Securities and Exchange Commission, enabling the company to sell up to $18.8 million of its common stock under an at-the-market offering through Needham & Company, L...
22nd Century Reports Strong Q3 Revenue and Profitability Gains
PositiveOn October 22, 2026, 22nd Century Group preliminarily reported unaudited financial results for the third quarter ended September 30, 2026, highlighting sharp revenue growth and improved profitability metrics from continuing operations. Net revenue ro...
22nd Century Expands Low-Nicotine Cigarette Retail Footprint
PositiveIn a mid-year shareholder letter dated September 1, 2026, 22nd Century reported progress in expanding its low-nicotine VLN® and Pinnacle cigarette brands, with products now in about 2,000 U.S. retail outlets and a goal of roughly 5,000 by year-end, i...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 20, 2026
